“CMS is pulling every lever to combat the opioid epidemic and increasing access to treatments for Americans suffering from substance use disorder is essential to addressing this issue,” Kimberly Brandt, CMS’ principal deputy administrator for policy and operations, said in a press release.
States must apply by Aug. 9. CMS plans to select proposals for an 18-month planning phase. When this 18-month period is over, the agency will choose five states to continue in a 36-month demonstration project.
More articles on opioids:
Addressing the national opioid epidemic through care collaboration
Many surgeons overprescribed opioids as overdose rates soared, KHN analysis finds
FDA proposes more stringent rules for opioid approval: 4 things to know
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
